A well-capitalized cancer immunotherapy company, operating in a highly competitive field, needed to benchmark its financial status and staff numbers against its peers to help gauge its competitive positioning and future financing needs.
Our cancer immunotherapy consulting team worked with the client to develop a list of comparable companies in the CAR-T and cancer immunotherapy space against which our client could be benchmarked. By analyzing SEC filings, company annual reports and other sources, we gathered extensive data about each of the companies and prepared a detailed report comparing our client to other companies across several different metrics.
We compared employee growth over time in different roles, expenditure per employee, research expenditures versus G&A expenditures, and the growth in employee number and expenditures in view of total fundraising. The completed report was presented at a company board meeting to help understand the competitive landscape and possible future strategic funding requirements.Back